Meta Platforms on Monday launched Meta Quest+, a subscription-based service for its virtual reality (VR) headsets to shape a nascent but high-investment market.
(Reuters) - Moderna said on Thursday it has completed the submission of a regulatory application to the U.S. Food and Drug Administration for its upda.
The submission from the company follows the FDA's advice last week to manufacturers that are updating their COVID-19 vaccines to develop monovalent shots to target XBB.1.5. Monovalent, or single-target, vaccines would be a change from the most recent bivalent COVID boosters that targeted both the original and Omicron strains of the coronavirus. Moderna said preliminary clinical data demonstrated a robust immune response by its XBB.1.5 monovalent vaccine against XBB descendent lineage viruses.
(Reuters) - Moderna said on Thursday it has completed the submission of a regulatory application to the U.S. Food and Drug Administration for its upda.